Report adverse events

THIS SITE IS NOT INTENDED OR DESIGNED FOR REPORTING OF ADVERSE EVENTS

ViroGates is required to document reports of adverse events, both for comprehensive safety monitoring of its products and also to fulfill reporting requirements to Regulatory Authorities. It allows continued monitoring of the benefit/risk balance of the medicinal product.

Adverse events should be reported. Reporting forms and information can be found at fda.gov or through the FDA Adverse Event Reporting System (FAERS). Adverse events should also be reported to ViroGates A/S. Please contact ViroGates Adverse Events by emailing adverse.events@virogates.com or calling +45 2113 1336.

Please provide the brand name and batch number, where possible. It is very important that safety surveillance is carried out on a brand/product specific basis to ensure the information collected is accurate.

Date of preparation: January 2021

900+

published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of 3 products:

Quick Triage

A Point of Care Solution

TurbiLatex

For Automated Systems

ELISA Assay

Clinical and Research

suPAR is used in clinical routine in 48 hospitals

48 hospitals use suPAR in clinical routine for triage of patients in the Emergency Departments and COVID-19 units. Clinical routine is defined by the placement of two Purchasing Orders within the last 12 months rolling.
This period covers January 1, 2022, until December 31, 2022. Some hospital locations cannot be disclosed due to confidentiality.

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates